TriSalus Life Sciences Inc
For the period ended Dec 31, 2023. Filed Apr 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 11, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Act, the registrant has duly caused this Annual Report on Form 10-K statement to be signed on its behalf by the undersigned, thereunto duly authorized, on the 11th day of April, 2024.
| TriSalus Life Science, Inc. | ||
| By: | /s/ Mary Szela | |
| Name: | Mary Szela | |
| Title: | Chief Executive Officer | |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mary Szela and Sean Murphy, and each of them, his or her true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Mary Szela | Chief Executive Officer and Director(Principal Executive Officer) | April 11, 2024 |
| Mary Szela | ||
| /s/ Sean Murphy | Chief Financial Officer and Director(Principal Financial and Accounting Officer) | April 11, 2024 |
| Sean Murphy | ||
| /s/ Mats Wahlström | Chairman | April 11, 2024 |
| Mats Wahlström | ||
| /s/ Arjun "JJ" Desai | Director | April 11, 2024 |
| Arjun "JJ" Desai | ||
| /s/ Andrew von Eschenbach | Director | April 11, 2024 |
| Andrew von Eschenbach | ||
| /s/ Kerry Hicks | Director | April 11, 2024 |
| Kerry Hicks | ||
| /s/ George Kelly Martin | Director | April 11, 2024 |
| George Kelly Martin | ||
| /s/ David J. Matlin | Director | April 11, 2024 |
| David J. Matlin | ||
| /s/ Anil K. Singhal | Director | April 11, 2024 |
| Anil K. Singhal | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.